» Articles » PMID: 35241807

The Physiology and Genetics of Bacterial Responses to Antibiotic Combinations

Overview
Date 2022 Mar 4
PMID 35241807
Authors
Affiliations
Soon will be listed here.
Abstract

Several promising strategies based on combining or cycling different antibiotics have been proposed to increase efficacy and counteract resistance evolution, but we still lack a deep understanding of the physiological responses and genetic mechanisms that underlie antibiotic interactions and the clinical applicability of these strategies. In antibiotic-exposed bacteria, the combined effects of physiological stress responses and emerging resistance mutations (occurring at different time scales) generate complex and often unpredictable dynamics. In this Review, we present our current understanding of bacterial cell physiology and genetics of responses to antibiotics. We emphasize recently discovered mechanisms of synergistic and antagonistic drug interactions, hysteresis in temporal interactions between antibiotics that arise from microbial physiology and interactions between antibiotics and resistance mutations that can cause collateral sensitivity or cross-resistance. We discuss possible connections between the different phenomena and indicate relevant research directions. A better and more unified understanding of drug and genetic interactions is likely to advance antibiotic therapy.

Citing Articles

mutations in with negative MPT64 antigen assay results from a tertiary hospital in Southeastern China.

Pan X, Zhou S, Jin L, Ji S, Lou X, Lu B Front Med (Lausanne). 2025; 12:1531853.

PMID: 40078396 PMC: 11898740. DOI: 10.3389/fmed.2025.1531853.


Eradication of Helicobacter pylori reshapes gut microbiota and facilitates the evolution of antimicrobial resistance through gene transfer and genomic mutations in the gut.

Zhao M, Zhang Y, Liu S, Wang F, Zhang P BMC Microbiol. 2025; 25(1):90.

PMID: 40000989 PMC: 11853306. DOI: 10.1186/s12866-025-03823-w.


Checkerboard synergistic data analysis using a Hill function-based approach.

Gutheil W bioRxiv. 2025; .

PMID: 39975223 PMC: 11839125. DOI: 10.1101/2025.02.05.636765.


Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer.

Wang N, Wu S, Huang L, Hu Y, He X, He J J Biomed Sci. 2025; 32(1):23.

PMID: 39966840 PMC: 11837407. DOI: 10.1186/s12929-025-01117-x.


Field Grand Challenge Frontiers in Antibiotics.

Gillespie S Front Antibiot. 2025; 1():897071.

PMID: 39816402 PMC: 11732104. DOI: 10.3389/frabi.2022.897071.


References
1.
Baquero F, Levin B . Proximate and ultimate causes of the bactericidal action of antibiotics. Nat Rev Microbiol. 2020; 19(2):123-132. PMC: 7537969. DOI: 10.1038/s41579-020-00443-1. View

2.
Kohanski M, Dwyer D, Collins J . How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010; 8(6):423-35. PMC: 2896384. DOI: 10.1038/nrmicro2333. View

3.
Lopatkin A, Bening S, Manson A, Stokes J, Kohanski M, Badran A . Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science. 2021; 371(6531). PMC: 8285040. DOI: 10.1126/science.aba0862. View

4.
Scott M, Gunderson C, Mateescu E, Zhang Z, Hwa T . Interdependence of cell growth and gene expression: origins and consequences. Science. 2010; 330(6007):1099-102. DOI: 10.1126/science.1192588. View

5.
Palmer A, Kishony R . Opposing effects of target overexpression reveal drug mechanisms. Nat Commun. 2014; 5:4296. PMC: 4408919. DOI: 10.1038/ncomms5296. View